Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough consumer sales cool: Schering-Plough's consumer health sales fell 5 percent to $381 million in the firm's fiscal 2009 second quarter "primarily due to lower sales of sun care products due to the unseasonable weather," according to Chief Financial Officer Bob Bertollini. Sun care sales fell 17 percent to $96 million compared to $115 million during the year-ago quarter. Sales of laxative MiraLAX reached $36 million, a 30 percent increase, according to a July 21 earnings statement. The MiraLAX growth helped offset a 10 percent drop of OTCClaritin sales to $108 million in the April-June period, Bertollini said during a same-day earnings call. Schering expects its merger with Merck to close in the fourth quarter (1"The Tan Sheet" March 16, 2009)